These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 389275)

  • 1. Myeloproliferative disorders terminating in acute micromegakaryoblastic leukaemia.
    Efrati P; Nir E; Yaari A; Berrebi A; Kaplan H; Dvilanski A
    Br J Haematol; 1979 Sep; 43(1):79-86. PubMed ID: 389275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelofibrosis in chronic granulocytic leukaemia.
    Clough V; Geary CG; Hashmi K; Davson J; Knowlson T
    Br J Haematol; 1979 Aug; 42(4):515-26. PubMed ID: 289409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
    Seewann HL; Jüttner F; Vykoupil KF
    Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocytic leukaemia as a phase of myeloproliferative disorders.
    Egner JR; Aabo D; Dimitrov NV
    Scand J Haematol; 1982 Feb; 28(2):186-91. PubMed ID: 7201156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comprehensive care of patients with thrombocythemia].
    Hrubisková K; Steruská M; Horváth A
    Vnitr Lek; 1987 Oct; 33(10):872-82. PubMed ID: 3479860
    [No Abstract]   [Full Text] [Related]  

  • 7. Megakaryoblastic termination of myeloproliferative disorders.
    Amin MB; Maeda K; Carey JL; Babu RV; Raman BK
    Henry Ford Hosp Med J; 1992; 40(1-2):122-6. PubMed ID: 1428963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spleen in myeloproliferative disorders.
    Goldman JM; Nolasco I
    Clin Haematol; 1983 Jun; 12(2):505-16. PubMed ID: 6352114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic myeloproliferative diseases].
    Sréter L
    Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
    [No Abstract]   [Full Text] [Related]  

  • 13. Megakaryoblastic transformation of a myeloproliferative disorder.
    Prematilleke MN; Cheng PN; Feng CS
    Ceylon Med J; 1989 Dec; 34(4):179-84. PubMed ID: 2627727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of acute leukaemia in myeloproliferative disorders.
    Rosenthal DS; Moloney WC
    Br J Haematol; 1977 Jul; 36(3):373-82. PubMed ID: 268210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytic sarcoma preceding leukaemic transformation in myelofibrosis.
    Jacobs P; Sellars S
    Postgrad Med J; 1985 Dec; 61(722):1069-71. PubMed ID: 3867868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and management of essential thrombocythemia.
    Beer PA; Green AR
    Hematology Am Soc Hematol Educ Program; 2009; ():621-8. PubMed ID: 20008247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 18. Synchronous Hodgkin's disease and myelofibrosis terminating with granulocytic sarcoma and acute megakaryocytic leukemia.
    Vukelja SJ; Krishnan J; Ward FT; Redmond J
    South Med J; 1990 Nov; 83(11):1317-20. PubMed ID: 2237564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha.
    Kikawa Y; Fukumoto Y; Obata K; Tamura S; Takeuchi M; Tanizawa A; Mayumi M
    J Pediatr Hematol Oncol; 1998; 20(5):463-6. PubMed ID: 9787320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic acquired sideroblastic anemia terminating in acute myelofibrosis: case report and review of leterature.
    Yeung K; Trowbridge AA
    Cancer; 1977 Jan; 39(1):359-65. PubMed ID: 318917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.